Skip to content

Effect of Esmolol on Perioperative Stress Reaction

Effect of Continuous Infusion of Esmolol on Perioperative Stress Reaction in Patients Undergoing Airway Intervention

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05694585
Enrollment
46
Registered
2023-01-23
Start date
2023-02-01
Completion date
2023-12-31
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Obstruction, Catecholamine; Overproduction, Esmolol, Stress Reaction

Keywords

continuous infusion

Brief summary

The goal of this clinical trial is to observe the effect of low dose continuous infusion of esmolol on perioperative stress response in patients undergoing airway intervention .

Detailed description

Airway intervention is known to activate stress response and release catecholamines resulting in severe hemodynamic instability. Various techniques which are recommended to prevent the stress response include increasing the depth of anesthesia, improving surgical procedures and the use of various pharmacological agents. Esmolol blocks the action of the endogenous catecholamines, we plan low dose esmolol infusion decrease stress response and hemodynamic fluctuation during airway intervention. 46 patients scheduled airway intervention under general anesthesia were randomly divided into esmolol group and control group. esmolol 50μg/kg/min or saline 50μg/kg/min were iv administered before Operation beginning. If HR(heart rate)is greater than 90 beats/min, esmolol or saline 50μg/kg/min is added each time, with interval more than 5 min and the peak value is 200 μg/kg/min. If the heart rate is lower than 60 times/minute, Stop medication. Plasma level of Norepinephrine, epinephrine, and cortisol before induction of anesthesia and 30 minutes after beginning of operation were determined by high-performance liquid chromatography. Perioperative hemodynamics changes, extubation time, incidence of severe sinus bradycardia and bronchospasm were recorded.

Interventions

DRUGEsmolol

Esmolol 50μg/kg /min is intravenously administered before Operation beginning. If HR(heart rate)is greater than 90 beats/min, esmolol 50μg/kg/min is added each time, with interval more than 5 min and the peak value is 200 μg/kg/min. If the heart rate is lower than 60 times/minute, Stop medication.

DRUGsaline

Saline 50μg/kg /min were iv administered before Operation beginning. If HR(heart rate)is greater than 90 beats/min, saline 50μg/kg/min is added each time, with interval more than 5 min and the peak value is 200 μg/kg/min. If the heart rate is lower than 60 times/minute, Stop medication.

Sponsors

Xiumei Song
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. American Society of Anesthesiologists (ASA) Physical Status I to III.; 2. Body mass index (BMI): 20-30 kg/m2; 3. Elective airway intervention under general anesthesia with jet ventilation,duration of operation less than 2hs; 4. Sign informed consent for clinical trial

Exclusion criteria

1. The patient and his or her family refused to participate in the study; 2. Severe respiratory or/cardiovascular or/ neurological disease, or/ hepatic or/renal dysfunction 3. Those who are allergic to the drugs used in this study; 4. Psychiatric history or with unstable mental state; 5. Patients with atrioventricular block 6. Patients with history of asthma 7. Patients now treated with β-adrenergic receptor blockers 8. Patients participating in other clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Changes in plasma norepinephrine levelsup to 30 minutes after beginning of operationlevel of Norepinephrine
Changes in plasma epinephrine levelsup to 30 minutes after beginning of operationlevel of epinephrine
Changes in plasma cortisol levelsup to 30 minutes after beginning of operationlevel of cortisol

Secondary

MeasureTime frameDescription
Hemodynamic changes :Systolic blood pressure(SBP )from anesthesia induction to 30 minutes after remove the laryngeal maskSystolic blood pressure (SBP ) during perioperative period
Hemodynamic changes :Diastolic blood pressure( DBP)from anesthesia induction to 30 minutes after remove the laryngeal maskDiastolic blood pressure( DBP) during perioperative period
Hemodynamic changes :Heart rate(HR)from anesthesia induction to 30 minutes after remove the laryngeal maskHeart rate(HR) during perioperative period
Incidence of adverse reactions: Severe sinus bradycardiafrom anesthesia induction to 30 minutes after remove the laryngeal maskSevere sinus bradycardia: HR\<40 times/min during perioperative period
Incidence of adverse reactions: bronchospasmfrom anesthesia induction to 30 minutes after remove the laryngeal maskPerioperative bronchospasm
Laryngeal mask airway (LMA) removal timeDuration from the end of anesthetics infusion to LMA removalDuration from the end of anesthetics infusion to LMA removal

Contacts

Primary ContactXiumei Song, M.D.
ssm801117@163.com13969050425

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026